OTC:VRBCF Virbac (VRBCF) Stock Price, News & Analysis → This Could be Your “Big Money” AI Moment (From InvestorPlace) (Ad) Free VRBCF Stock Alerts $384.42 0.00 (0.00%) (As of 05/21/2024 ET) Add Compare Share Share Today's Range$384.42▼$384.4250-Day Range$345.50▼$385.6052-Week Range$288.00▼$385.60VolumeN/AAverage Volume100 shsMarket CapitalizationN/AP/E Ratio58.12Dividend Yield0.49%Price TargetN/A Stock AnalysisStock AnalysisChartHeadlinesStock AnalysisChartHeadlines Get Virbac alerts: Email Address Ad StocksToTradeWrite this ticker symbol down…A megatrend now poised to mint a brand-new wave of millionaires right here in America. And today, self-made millionaire Tim Bohen is giving you an inside look at the megatrend that’s going to change everything.Discover the #1 company leading this revolution About Virbac Stock (OTC:VRBCF)Virbac SA manufactures and sells a range of products and services for companion animals and farm animals in France, Europe, Latin America, North America, Asia, Pacific, and Africa and the Middle East. The company offers a range of vaccines, dental hygiene, reproduction, dermatology, parasiticides, diagnostic, antibiotics, and aquaculture products; and veterinary medicines for anesthesia, geriatrics, behavior, and injectable micronutrients, as well as petfood and electronic identification. It serves veterinarians, farmers, and pet owners. Virbac SA was founded in 1968 and is headquartered in Carros, France.Read More VRBCF Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart VRBCF Stock News HeadlinesMay 17, 2024 | americanbankingnews.comVirbac (OTC:VRBCF) Shares Up 8.4%April 18, 2024 | investing.comStifel raises Virbac share price target citing strong Q1 and Sasaeah acquisition impactApril 11, 2024 | finance.yahoo.comVirbac : Declaration of the number of shares and voting rights 03/2024March 19, 2024 | finance.yahoo.comVIRBAC: 2023 ANNUAL RESULTSMarch 11, 2024 | finance.yahoo.comVirbac : Declaration of the number of shares and voting rights 02/2024February 6, 2024 | finance.yahoo.comVirbac : Declaration of the number of shares and voting rights 01/2024February 4, 2024 | finance.yahoo.comVirbac SA (VIRP.PA)January 8, 2024 | finance.yahoo.comVirbac : Declaration of the number of shares and voting rights 12/2023December 23, 2023 | morningstar.comVirbac SA VIRPDecember 21, 2023 | marketwatch.comVirbac Shares Rise After Company Lifts OutlookDecember 7, 2023 | finance.yahoo.comVirbac : Declaration of the number of shares and voting rights 11/2023November 9, 2023 | finance.yahoo.comVirbac : Declaration of the number of shares and voting rights 10/2023November 2, 2023 | finance.yahoo.comVIRBAC: Virbac acquired a majority stake in Globion, a leading Indian poultry vaccines specialistOctober 16, 2023 | finance.yahoo.comVirbac : Declaration of the number of shares and voting rights 0/2023October 9, 2023 | finance.yahoo.comVirbac will enter the fast-growing poultry vaccines segment in IndiaAugust 26, 2023 | finance.yahoo.comVirbac launches a share buyback programSeptember 14, 2022 | finance.yahoo.comVirbac : Declaration of the number of shares and voting rights 08/2022September 14, 2022 | finance.yahoo.comVirbac : Declaration of the number of shares and voting rights 07/2022July 11, 2022 | uk.finance.yahoo.comFactors that might predict the Virbac SA share price directionJune 5, 2022 | finance.yahoo.comVirbac : Declaration of the number of shares and voting rights 05/2022June 4, 2022 | sg.finance.yahoo.comVirbac : Declaration of the number of shares and voting rights 04/2022March 2, 2022 | uk.finance.yahoo.comVirbac : Declaration of the number of shares and voting rights 01/2022March 2, 2022 | finance.yahoo.comVirbac : Declaration of the number of shares and voting rights 02/2022See More Headlines Receive VRBCF Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Virbac and its competitors with MarketBeat's FREE daily newsletter. Email Address Industry, Sector and Symbol Stock ExchangeOTC SectorMedical Industry Drug Manufacturers - General Sub-IndustryN/A Current SymbolOTC:VRBCF CUSIPN/A CIKN/A Webwww.virbac.fr Phone33.4.92.08.71.00FaxN/AEmployees5,459Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E Ratio58.12 Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding SharesN/AFree FloatN/AMarket CapN/A OptionableNot Optionable BetaN/A These 7 Stocks Will Be Magnificent in 2024With average gains of 150% since the start of 2023, now is the time to give these stocks a look and pump up your 2024 portfolio.Get This Free Report Key ExecutivesMr. Sebastien Huron (Age 53)CEO & Chairman of the Executive Board Comp: $647.62kMr. Habib Ramdani (Age 48)CFO, Deputy CEO & Member of Executive Board Comp: $336.8kMr. Marc Bistuer (Age 62)Deputy CEO and Director of Corporate Quality & Compliance Comp: $315.23kMs. Sandrine BrunelHead of Corporate CommunicationsMs. Nathalie PolletHead of Global Marketing & Market DevelopmentMs. Francesca CortellaHead of Corporate Human ResourcesMs. Sophie FaviniHead of Global Business OperationsMr. Bertrand HavrileckHead of Corporate R&DManuela RodríguezDirector of Financial ProjectsMore ExecutivesKey CompetitorsAstraZenecaOTCMKTS:AZNCFCosmo PharmaceuticalsOTC:CMOPFCSPC Pharmaceutical GroupOTCMKTS:CSPCYDaiichi SankyoOTCMKTS:DSNKYDechra PharmaceuticalsOTCMKTS:DCHPFView All Competitors VRBCF Stock Analysis - Frequently Asked Questions How have VRBCF shares performed in 2024? Virbac's stock was trading at $288.00 on January 1st, 2024. Since then, VRBCF shares have increased by 33.5% and is now trading at $384.42. View the best growth stocks for 2024 here. Is Virbac a good dividend stock? Virbac (OTC:VRBCF) pays an annual dividend of $1.90 per share and currently has a dividend yield of 1.15%. The dividend payout ratio is 28.73%. This payout ratio is at a healthy, sustainable level, below 75%. How do I buy shares of Virbac? Shares of VRBCF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (OTC:VRBCF) was last updated on 5/21/2024 by MarketBeat.com Staff From Our PartnersBill Clinton Backing Biden Replacement???The Freeport SocietyWrite this ticker symbol down…StocksToTradeShocking $16T Elon Musk Crypto LeakCrypto 101 MediaExposed: 10 CENT Crypto to Explode May 20th?True Market InsidersThe ONE AI Stock to own now. (It’s not Nvidia.)Weiss RatingsWarren Buffett's "mystery stock"Stansberry ResearchNew Options need New Trading StrategiesNetpicksThis military-backed stock “owns” AI marketPorter & Company Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Virbac SA Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
